Datebao Secures Tens of Millions in Series B+ Funding, Valuation Reaches $200 Million

Datbao, an online platform for personal health insurance services, announced today that it had recently completed a Series B+ financing round worth tens of millions of U.S. dollars, just four months after closing its Series B round in February this year. The latest round was led by existing investor China Development Capital (Taiwan), with Fosun Group participating as a co-investor. Following this round, Datbao’s valuation has reached $200 million.

Zhou Lei, CEO of Dataibao, stated that the new round of financing will be primarily used to actively build and continuously improve Dataibao’s medical security ecosystem, further driving commercial insurance to participate at the source in individual healthcare “payment.”

In the future, Dataobao will break with tradition in the internet insurance sector by launching three major systems: a health insurance product platform, a personal health management platform, and a medical service platform. These will provide individuals with comprehensive, multi-dimensional health services that integrate disease screening and prevention, health management, medical services, and risk protection. It is reported that Dataobao has established a new Health Management Division, which will lead the integration of cross-industry resources, including health management service organizations and healthcare institutions.

Currently, Datebao boasts over 5 million high-quality health insurance users. In the first half of this year, against the backdrop of a general decline in premiums across the insurance industry, Datebao’s premiums continued to grow steadily, achieving an explosive 500% growth in May alone.

Currently, DataBao has launched dozens of products, including critical illness insurance, medical insurance, and accident insurance, continuously addressing users’ key pain points. These offerings include mid-tier medical insurance (“DataBao Medical Insurance”), critical illness insurance for the elderly (“Xiaoqin Bao”), targeted insurance products for women, childhood vaccine insurance, and pediatric eczema insurance—products that are scarce in the industry.

Da Te Bao was established in July 2014 as China’s first insurance service platform to hold a national online insurance brokerage license, focusing on personal health insurance and health services. At its inception, it secured angel investment from Dewo and Xianfeng Huaxing, and completed an RMB 180 million Series A financing round within six months of its launch.